Ustekinumab for the treatment of adults with moderate to severe psoriasis. National Institute for Health and Clinical Excellence (NICE).

Guideline Title
Ustekinumab for the treatment of adults with moderate to severe psoriasis.

Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Ustekinumab for the treatment of adults with moderate to severe psoriasis. London (UK): National Institute for Health and Clinical Excellence (NICE); 2009 Sep. 31 p. (Technology appraisal guidance; no. 180).

Guideline Status
This is the current release of the guideline.

full-text:
http://guideline.gov/content.aspx?f=rss&id=15548